281 related articles for article (PubMed ID: 30428849)
1. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
Li G; Wu W; Zhang X; Huang Y; Wen Y; Li X; Gao R
BMC Nephrol; 2018 Nov; 19(1):326. PubMed ID: 30428849
[TBL] [Abstract][Full Text] [Related]
2. Serum TNF-
Wu H; Wen Y; Yue C; Li X; Gao R
Dis Markers; 2020; 2020():5514145. PubMed ID: 33299497
[TBL] [Abstract][Full Text] [Related]
3. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
[TBL] [Abstract][Full Text] [Related]
4. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
5. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
Rostoker G; Rymer JC; Bagnard G; Petit-Phar M; Griuncelli M; Pilatte Y
Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy.
Gan Y; Cai Y; Li J; Wu J; Zhang R; Han Q; Li W; Yang Q
Int J Med Sci; 2024; 21(4):674-680. PubMed ID: 38464822
[No Abstract] [Full Text] [Related]
7. Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features.
Xin G; Shi W; Xu LX; Su Y; Yan LJ; Li KS
J Nephrol; 2013; 26(4):683-90. PubMed ID: 23042433
[TBL] [Abstract][Full Text] [Related]
8. Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study.
Bi TD; Zheng JN; Zhang JX; Yang LS; Liu N; Yao L; Liu LL
BMC Nephrol; 2019 Jul; 20(1):244. PubMed ID: 31272400
[TBL] [Abstract][Full Text] [Related]
9. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
10. Increased Tim-3
Hou J; Zhang L; Wu H; Gao P; Xu Z
Int Immunopharmacol; 2021 Aug; 97():107666. PubMed ID: 34058623
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
[TBL] [Abstract][Full Text] [Related]
12. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses.
Zhang YM; Zhou XJ; Shi SF; Liu LJ; Lyu JC; Zhang H
Chin Med J (Engl); 2020 Feb; 133(3):277-284. PubMed ID: 31929371
[TBL] [Abstract][Full Text] [Related]
14. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM
Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344
[TBL] [Abstract][Full Text] [Related]
15. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
[TBL] [Abstract][Full Text] [Related]
16. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
Zhang Q; Zhao Y; Luo Y; Guo S; Hou H; Han X; Zhou Y
Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
Shin JR; Kim SM; Yoo JS; Park JY; Kim SK; Cho JH; Jeong KH; Lee TW; Ihm CG
Korean J Intern Med; 2014 May; 29(3):334-40. PubMed ID: 24851068
[TBL] [Abstract][Full Text] [Related]
18. Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy.
Li Z; Han Q; Ye H; Li J; Wei X; Zhang R; Huang Q; Xu Y; Liu G; Li B; Yang Q
BMC Nephrol; 2022 Feb; 23(1):78. PubMed ID: 35196994
[TBL] [Abstract][Full Text] [Related]
19. Severity of nephrotic IgA nephropathy according to the Oxford classification.
Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
[TBL] [Abstract][Full Text] [Related]
20. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
